Daughter's Death Inspired Woman to Help Others

After her daughter lost her fight with Hodgkin's Lymphoma, this woman was inspired to care for others:

"There is an armchair in the living room of Fran Sax’s apartment covered with the stuffed toys that her patients have asked her to care for: Minnie Mouse sits next to a baby doll, bobbing on a sea of teddy bears.

But Ms. Sax is a hospice volunteer and her patients are terminally ill, which means she has essentially been asked to look after them forever.

“I think hospice provides all of the things that family members cannot supply at the end of life,” said Ms. Sax, 81, who worked for 48 years as a registered nurse. “And I didn’t realize until it happened to me.”

Twelve years ago, her daughter, Mary, a videotape editor at CBS News, died from a recurrence of Hodgkin’s lymphoma that first surfaced when she was 18. “She said, ‘Mom, I beat this before, I can do it again,’ ” Ms. Sax said. But the cancer, which was first identified in her thyroid, had metastasized to her lungs, bones and brain, and after five months of chemotherapy, she died."

Read More: http://www.nytimes.com/2010/12/03/nyregion/03neediest.html

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap